5 Most Undervalued Biotech Stocks to Buy Right Now

Page 1 of 5

In this article, we will list the 5 Most Undervalued Biotech Stocks to Buy Right Now. Please visit 8 Most Undervalued Biotech Stocks to Buy Right Now if you would like to see the extended list and the methodology behind it.

5 Most Undervalued Biotech Stocks to Buy Right Now

5. ADMA Biologics Inc. (NASDAQ:ADMA)

ADMA Biologics Inc. (NASDAQ:ADMA) is one of the most undervalued biotech stocks to buy right now. Cantor Fitzgerald downgraded ADMA Biologics Inc. (NASDAQ:ADMA) to Neutral from Overweight on March 26, without assigning a price target. The firm stated that it spoke with a number of investors after a short report’s claim that ADMA Biologics Inc. (NASDAQ:ADMA) is boosting Asceniv revenues through channel stuffing, and stated that investors are disappointed over the company’s response and lack of direct communication after the report. The firm further contended that although the company put out a statement, they were “hoping to have more specific feedback addressing the direct claims in the report”. The firm also cited the lack of clarity and concerns associated with the increased days’ sales outstanding and accounts receivable for the downgrade.

ADMA Biologics Inc. (NASDAQ:ADMA) issued a statement refuting the allegations by Culper Research on March 27, calling them “unsubstantiated, misleading, and inaccurate”. The company did so to “alleviate confusion in the marketplace” regarding the company’s operations and business practices.

ADMA Biologics Inc. (NASDAQ:ADMA) is a biopharmaceutical company that manufactures, markets, and develops specialty plasma-derived biologics. Its operations are divided into the following business segments: ADMA BioManufacturing and Plasma Collection Center.

Page 1 of 5